1. 2142. Safety and immunogenicity of COVID Influenza Combination Vaccine. (15th December 2022) Authors: Shinde, Vivek; Woo, Wayne; Liu, Sharon; Cook, Sara; Santiago, Zenaida; Neal, Susan; Plested, Joyce S; Vincent, Tim; Zhu, Mingzhu; Cloney-Clark, Shane; Cho, Iksung; Fries, Lou; Glenn, Greg Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial. Issue 1 (January 2022) Authors: Shinde, Vivek; Cho, Iksung; Plested, Joyce S; Agrawal, Sapeckshita; Fiske, Jamie; Cai, Rongman; Zhou, Haixia; Pham, Xuan; Zhu, Mingzhu; Cloney-Clark, Shane; Wang, Nan; Zhou, Bin; Lewis, Maggie; Price-Abbott, Patty; Patel, Nita; Massare, Michael J; Smith, Gale; Keech, Cheryl; Fries, Louis; Glenn, ... Journal: Lancet infectious diseases Issue: Volume 22:Issue 1(2022) Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial. Issue 5 (May 2022) Authors: Madhi, Shabir A; Moodley, Dhayendre; Hanley, Sherika; Archary, Moherndran; Hoosain, Zaheer; Lalloo, Umesh; Louw, Cheryl; Fairlie, Lee; Fouche, Leon Frederik; Masilela, Mduduzi S L; Singh, Nishanta; Grobbelaar, Coert; Ahmed, Khatija; Benadé, Gabriella; Bhikha, Sutika; Bhorat, As'ad Ebrahim; Bhorat... Journal: Lancet Issue: Volume 9:Issue 5(2022) Page Start: e309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LB746. Safety and Immunogenicity of a Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) in Adults from the PREVENT-19 Trial in the United States. (15th December 2022) Authors: Áñez, Germán; Dunkle, Lisa M; Gay, Cynthia L; Kotloff, Karen L; Patel, Nita; Plested, Joyce S; McGarry, Alice; Woo, Wayne; Cai, Rongman; Cho, Iksung Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial. Issue 11 (November 2022) Authors: Mallory, Raburn M; Formica, Neil; Pfeiffer, Susan; Wilkinson, Bethanie; Marcheschi, Alex; Albert, Gary; McFall, Heather; Robinson, Michelle; Plested, Joyce S; Zhu, Mingzhu; Cloney-Clark, Shane; Zhou, Bin; Chau, Gordon; Robertson, Andreana; Maciejewski, Sonia; Hammond, Holly L; Baracco, Lauren; Lo... Journal: Lancet infectious diseases Issue: Volume 22:Issue 11(2022) Page Start: 1565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Issue 2 (February 2022) Authors: Toback, Seth; Galiza, Eva; Cosgrove, Catherine; Galloway, James; Goodman, Anna L; Swift, Pauline A; Rajaram, Sankarasubramanian; Graves-Jones, Alison; Edelman, Jonathan; Burns, Fiona; Minassian, Angela M; Cho, Iksung; Kumar, Lakshmi; Plested, Joyce S; Rivers, E Joy; Robertson, Andreana; Dubovsky,... Journal: Lancet Issue: Volume 10:Issue 2(2022) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗